Neostigmine Methylsulfate | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Neostigmine Methylsulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 10 USDMF, 6 CEP/COS, 2 JDMF, 11 EU WC, 11 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

71 FDF Dossiers, 42 FDA Orange Book, 1 Europe, 8 Canada, 2 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/ML), SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML), SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML), SOLUTION;INTRAVENOUS - 5MG/5ML (1MG/ML)

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 32 NEWS #PharmaBuzz

MARKET PLACE

9 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 USP, 3 JP, 1 Others

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1USP

filter CAS Number Reset all filters

filter Details Reset all filters

filter Country Reset all filters

Product Main Page

01

USP

2024 ACI Convention

Not Confirmed

Contact us
to update this info